# Near Normalisation of BG Improves the Potentiating Effect of GLP-1

> **NCT00612625** · NA · COMPLETED · sponsor: **Hvidovre University Hospital** · enrollment: 9 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** glucagon-like peptide-1
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00612625
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2004-07
- **Final completion:** 2004-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2008-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612625, "Near Normalisation of BG Improves the Potentiating Effect of GLP-1". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00612625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*